Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
UCM05 is an inhibitor of fatty acid synthase that strongly suppresses the growth of human breast cancer cell lines (IC50 = 21 µM for SK-BR-3 cells).1,2 It does not alter carnitine palmitoyltransferase 1 activity or induce weight loss in mice.1,2 UCM05 can reduce cleavage of poly(ADP-ribose) polymerase, phosphorylation of HER2, Akt, and ERK1/2, and growth of established xenografts in vivo.3 UCM05 also blocks the GTP-binding site of the cell division protein FtsZ from Bacillus, preventing bacterial division.4
WARNING This product is not for human or veterinary use.
1. Novel inhibitors of fatty acid synthase with anticancer activity. Clin. Cancer Res. 15(24), 7608-7615 (2009).
2. New synthetic inhibitors of fatty acid synthase with anticancer activity. J. Med. Chem. 55(11), 5013-5023 (2012).
3. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-
4. Synthetic inhibitors of bacterial cell division targeting the GTP-